BCWORLD PHARM. Co., Ltd. (KOSDAQ: 200780)
South Korea
· Delayed Price · Currency is KRW 4,680.00
-60.00 (-1.27%)
Nov 15, 2024, 9:00 AM KST
BCWORLD PHARM. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 72,959 | 75,111 | 72,703 | 62,079 | 57,030 | 51,497 | Upgrade
|
| Other Revenue | - | - | -0 | - | -0 | -0 | Upgrade
|
| Revenue | 72,959 | 75,111 | 72,703 | 62,079 | 57,030 | 51,497 | Upgrade
|
| Revenue Growth (YoY) | -4.27% | 3.31% | 17.11% | 8.85% | 10.74% | -6.01% | Upgrade
|
| Cost of Revenue | 45,098 | 43,234 | 45,497 | 42,149 | 36,679 | 33,778 | Upgrade
|
| Gross Profit | 27,861 | 31,876 | 27,206 | 19,931 | 20,351 | 17,719 | Upgrade
|
| Selling, General & Admin | 20,222 | 20,302 | 21,261 | 11,662 | 10,850 | 9,678 | Upgrade
|
| Research & Development | 2,438 | 1,198 | 770.66 | 9,298 | 10,951 | 8,444 | Upgrade
|
| Other Operating Expenses | 283.11 | 132.24 | 58.84 | 200.34 | 219.58 | 141.95 | Upgrade
|
| Operating Expenses | 26,981 | 25,511 | 25,344 | 21,464 | 22,448 | 18,724 | Upgrade
|
| Operating Income | 880.27 | 6,365 | 1,862 | -1,534 | -2,096 | -1,005 | Upgrade
|
| Interest Expense | -5,053 | -5,234 | -3,792 | -2,169 | -2,418 | -1,345 | Upgrade
|
| Interest & Investment Income | 191.84 | 187.98 | 129.42 | 180.31 | 221.69 | 129.63 | Upgrade
|
| Currency Exchange Gain (Loss) | 114.04 | 110.63 | 376.05 | 317.28 | -367.75 | 113.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 271.67 | -285.96 | 501.3 | 498.41 | 1,634 | -416.6 | Upgrade
|
| EBT Excluding Unusual Items | -3,595 | 1,144 | -923.13 | -2,707 | -3,026 | -2,524 | Upgrade
|
| Gain (Loss) on Sale of Investments | -32.61 | 13.42 | -535.17 | -229.14 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 47.16 | 48.91 | -0.32 | -0 | 198.74 | 56.99 | Upgrade
|
| Asset Writedown | - | - | -64.29 | - | -2.36 | -105 | Upgrade
|
| Pretax Income | -3,581 | 1,206 | -1,523 | -2,936 | -2,830 | -2,572 | Upgrade
|
| Income Tax Expense | 2,892 | -1,686 | -1,583 | 42.06 | -635.66 | -833.04 | Upgrade
|
| Earnings From Continuing Operations | -6,473 | 2,892 | 59.78 | -2,978 | -2,194 | -1,739 | Upgrade
|
| Minority Interest in Earnings | -424 | -258.52 | 221.52 | 1,135 | 614.15 | 186.2 | Upgrade
|
| Net Income | -6,897 | 2,634 | 281.3 | -1,843 | -1,580 | -1,553 | Upgrade
|
| Net Income to Common | -6,897 | 2,634 | 281.3 | -1,843 | -1,580 | -1,553 | Upgrade
|
| Net Income Growth | - | 836.31% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 9 | 9 | 9 | 9 | Upgrade
|
| Shares Change (YoY) | -0.40% | -0.98% | -0.19% | 0.35% | -0.73% | 0.73% | Upgrade
|
| EPS (Basic) | -817.30 | 312.11 | 33.01 | -215.85 | -185.68 | -182.48 | Upgrade
|
| EPS (Diluted) | -817.30 | 312.11 | 33.01 | -215.85 | -185.68 | -182.48 | Upgrade
|
| EPS Growth | - | 845.59% | - | - | - | - | Upgrade
|
| Free Cash Flow | 4,582 | 8,361 | 666.21 | -18,064 | -13,288 | -9,208 | Upgrade
|
| Free Cash Flow Per Share | 542.95 | 990.78 | 78.17 | -2115.59 | -1561.59 | -1074.26 | Upgrade
|
| Dividend Per Share | 100.000 | 100.000 | - | - | 100.000 | - | Upgrade
|
| Gross Margin | 38.19% | 42.44% | 37.42% | 32.11% | 35.68% | 34.41% | Upgrade
|
| Operating Margin | 1.21% | 8.47% | 2.56% | -2.47% | -3.68% | -1.95% | Upgrade
|
| Profit Margin | -9.45% | 3.51% | 0.39% | -2.97% | -2.77% | -3.02% | Upgrade
|
| Free Cash Flow Margin | 6.28% | 11.13% | 0.92% | -29.10% | -23.30% | -17.88% | Upgrade
|
| EBITDA | 8,485 | 13,835 | 9,070 | 3,641 | 2,473 | 2,654 | Upgrade
|
| EBITDA Margin | 11.63% | 18.42% | 12.48% | 5.86% | 4.34% | 5.15% | Upgrade
|
| D&A For EBITDA | 7,605 | 7,470 | 7,208 | 5,174 | 4,569 | 3,659 | Upgrade
|
| EBIT | 880.27 | 6,365 | 1,862 | -1,534 | -2,096 | -1,005 | Upgrade
|
| EBIT Margin | 1.21% | 8.47% | 2.56% | -2.47% | -3.68% | -1.95% | Upgrade
|
| Advertising Expenses | - | 1,274 | 1,505 | 1,085 | 728.19 | 219.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.